These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 4825234)

  • 1. Adrenergic modulation of pancreatic glucagon secretion in man.
    Gerich JE; Langlois M; Noacco C; Schneider V; Forsham PH
    J Clin Invest; 1974 May; 53(5):1441-6. PubMed ID: 4825234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of adrenergic control of glucagon secretion from isolated perfused rat pancreas.
    Filipponi P; Marcelli M; Nicoletti I; Pacifici R; Santeusanio F; Brunetti P
    Diabete Metab; 1982 Dec; 8(4):313-8. PubMed ID: 7160520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
    Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
    J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of alpha adrenoreceptor stimulants infused intrapancreatically on glucagon and insulin secretion.
    Kaneto A; Kajinuma H; Kosaka K
    Horm Metab Res; 1977 Jul; 9(4):267-71. PubMed ID: 892690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenergic modulation of insulin and glucagon secretion from the isolated perfused rat pancreas.
    Narimiya M; Yamada H; Matsuba I; Ikeda Y; Tanese T; Abe M
    Endocrinol Jpn; 1981 Jun; 28(3):281-92. PubMed ID: 6273141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adrenergic control of pancreatic glucagon secretion].
    Filipponi P; Nicoletti I; Santori P; Marcelli M; Santeusanio F
    Boll Soc Ital Biol Sper; 1981 May; 57(10):1068-74. PubMed ID: 6271149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man.
    Rizza RA; Cryer PE; Haymond MW; Gerich JE
    J Clin Invest; 1980 Mar; 65(3):682-9. PubMed ID: 6243675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of adrenergic receptor blockade on the exercise-induced rise in pancreatic polypeptide in man.
    Berger D; Floyd JC; Lampman RM; Fajans SS
    J Clin Endocrinol Metab; 1980 Jan; 50(1):33-9. PubMed ID: 7350185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
    Knudtzon J
    Horm Metab Res; 1984 Aug; 16(8):415-22. PubMed ID: 6381275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic modulation of pancreatic glucagon and insulin secretion in sheep.
    Oda S; Hagino A; Ohneda A; Sasaki Y; Tsuda T
    Am J Physiol; 1988 Mar; 254(3 Pt 2):R518-23. PubMed ID: 2894779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenergic modulation of glucagon and insulin secretion in obese and lean humans.
    Atkinson RL; Dahms WT; Bray GA; Sperling MA
    Horm Metab Res; 1981 May; 13(5):249-53. PubMed ID: 7021385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of alpha-adrenergic stimulation and its blockade on glucose turnover in man.
    Rizza RA; Haymond MW; Miles JM; Verdonk CA; Cryer PE; Gerich JE
    Am J Physiol; 1980 May; 238(5):E467-72. PubMed ID: 6990786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine during alpha- or beta-adrenergic blockade in man. Hormonal, metabolic, and cardiovascular effects.
    Lorenzi M; Karam JH; Tsalikian E; Bohannon NV; Gerich JE; Forsham PH
    J Clin Invest; 1979 Feb; 63(2):310-7. PubMed ID: 34629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenergic control of somatostatin release.
    Boden G; Master RW; Sattler MA; Martin JS; Tansy MF; Owen OE
    Endocrinology; 1982 Oct; 111(4):1166-72. PubMed ID: 6126351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alternations of plasma free fatty acid levels on pancreatic glucagon secretion in man.
    Gerich JE; Langlois M; Schneider V; Karam JH; Noacco C
    J Clin Invest; 1974 May; 53(5):1284-9. PubMed ID: 4825225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenergic modulation of human pancreatic polypeptide (hPP) release.
    Sive AA; Vinik AI; Levitt N
    Gastroenterology; 1980 Oct; 79(4):665-72. PubMed ID: 6997131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α- or β-Adrenergic blockade does not affect transplanted islet cell responses to hypoglycemia in type 1 diabetes.
    Rickels MR; Bellin MD; Stefanovski D; Peleckis AJ; Dalton-Bakes C; Markmann E; Nguyen HL; Townsend RR; Hering BJ; Naji A
    Am J Physiol Endocrinol Metab; 2024 Sep; 327(3):E290-E301. PubMed ID: 38984949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenergic mechanisms of catecholamine action on glucose homeostasis in man.
    Rizza RA; Cryer PE; Haymond MW; Gerich JE
    Metabolism; 1980 Nov; 29(11 Suppl 1):1155-63. PubMed ID: 7001182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of somatostatin and adrenergic blockade on glucagon, insulin and glucose in exercising sheep.
    Brockman RP; Halvorson R
    Aust J Biol Sci; 1981; 34(5-6):551-60. PubMed ID: 6122438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.